Market Research Logo

Global Therapeutic Nuclear Medicines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

Global Therapeutic Nuclear Medicines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

In the last several years, global market of Therapeutic Nuclear Medicines developed rapidly, with an average growth rate of 22.9%. In 2018, global revenue of Therapeutic Nuclear Medicines is nearly 855 M USD; the actual production is about 1000 thousand units.

This study researches the market size of Therapeutic Nuclear Medicines, presents the global Therapeutic Nuclear Medicines sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2019, and forecast to 2025.

This report focuses on the key data information of Therapeutic Nuclear Medicines in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Therapeutic Nuclear Medicines for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2017 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors analysis.

This report includes the following manufacturers: (we can also add the other companies as you want)
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Market Segment by Product Type
Radium-223
Lutetium-177
Iodine-131
Other

Market Segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Middle East
Africa


1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type
1.3.2 Radium-223
1.3.3 Lutetium-177
1.3.4 Iodine-131
1.4 Market Segment by Application
1.4.1 Global Therapeutic Nuclear Medicines Market Share by Application (2018-2025)
1.4.2 Thyroid
1.4.3 Bone Metastasis
1.4.4 Lymphoma
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Nuclear Medicines Market Size
2.1.1 Global Therapeutic Nuclear Medicines Revenue 2013-2025
2.1.2 Global Therapeutic Nuclear Medicines Sales 2013-2025
2.2 Therapeutic Nuclear Medicines Growth Rate by Regions
2.2.1 Global Therapeutic Nuclear Medicines Sales by Regions 2013-2018
2.2.2 Global Therapeutic Nuclear Medicines Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Therapeutic Nuclear Medicines Sales by Manufacturers
3.1.1 Therapeutic Nuclear Medicines Sales by Manufacturers 2017-2018
3.1.2 Therapeutic Nuclear Medicines Sales Market Share by Manufacturers 2017-2018
3.2 Revenue by Manufacturers
3.2.1 Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2018)
3.2.2 Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio
3.3 Therapeutic Nuclear Medicines Price by Manufacturers
3.4 Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market
3.6 Key Manufacturers Therapeutic Nuclear Medicines Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Radium-223 Sales and Revenue (2013-2018)
4.1.2 Lutetium-177 Sales and Revenue (2013-2018)
4.1.3 Iodine-131 Sales and Revenue (2013-2018)
4.2 Global Therapeutic Nuclear Medicines Sales Market Share by Type
4.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type
4.4 Therapeutic Nuclear Medicines Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Therapeutic Nuclear Medicines Sales by Application
6 North America
6.1 North America Therapeutic Nuclear Medicines Breakdown Data by Company
6.2 North America Therapeutic Nuclear Medicines Breakdown Data by Type
6.3 North America Therapeutic Nuclear Medicines Breakdown Data by Application
6.4 North America Therapeutic Nuclear Medicines Breakdown Data by Countries
6.4.1 North America Therapeutic Nuclear Medicines Sales by Countries
6.4.2 North America Therapeutic Nuclear Medicines Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Therapeutic Nuclear Medicines Breakdown Data by Company
7.2 Europe Therapeutic Nuclear Medicines Breakdown Data by Type
7.3 Europe Therapeutic Nuclear Medicines Breakdown Data by Application
7.4 Europe Therapeutic Nuclear Medicines Breakdown Data by Countries
7.4.1 Europe Therapeutic Nuclear Medicines Sales by Countries
7.4.2 Europe Therapeutic Nuclear Medicines Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Company
8.2 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Type
8.3 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Application
8.4 Asia Pacific Therapeutic Nuclear Medicines Breakdown Data by Countries
8.4.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Countries
8.4.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Southeast Asia
9 Central & South America
9.1 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Company
9.2 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Type
9.3 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Application
9.4 Central & South America Therapeutic Nuclear Medicines Breakdown Data by Countries
9.4.1 Central & South America Therapeutic Nuclear Medicines Sales by Countries
9.4.2 Central & South America Therapeutic Nuclear Medicines Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Type
10.2 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Application
10.3 Middle East and Africa Therapeutic Nuclear Medicines Breakdown Data by Countries
10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries
10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries
10.3.3 Middle East
10.3.4 Africa
11 Analysis of Therapeutic Nuclear Medicines Industry Key Manufacturers
11.1 Bayer
11.1.1 Company Profile
11.1.2 Product Information
11.1.3 Sales, Price and Revenue
11.2 Novartis
11.2.1 Company Profile
11.2.2 Product Information
11.2.3 Sales, Price and Revenue
11.3 China Isotope & Radiation
11.3.1 Company Profile
11.3.2 Product Information
11.3.3 Sales, Price and Revenue
11.4 Dongcheng
11.4.1 Company Profile
11.4.2 Product Information
11.4.3 Sales, Price and Revenue
11.5 Q BioMed
11.5.1 Company Profile
11.5.2 Product Information
11.5.3 Sales, Price and Revenue
11.6 Curium Pharmaceuticals
11.6.1 Company Profile
11.6.2 Product Information
11.6.3 Sales, Price and Revenue
11.7 Jubilant DraxImage
11.7.1 Company Profile
11.7.2 Product Information
11.7.3 Sales, Price and Revenue
11.8 Lantheus
11.8.1 Company Profile
11.8.2 Product Information
11.8.3 Sales, Price and Revenue
11.9 Spectrum Pharmaceuticals
11.9.1 Company Profile
11.9.2 Product Information
11.9.3 Sales, Price and Revenue
11.10 Progenics Pharmaceuticals
11.10.1 Company Profile
11.10.2 Product Information
11.10.3 Sales, Price and Revenue
11.11 International Isotopes
11.11.1 Company Profile
11.11.2 Product Information
11.11.3 Sales, Price and Revenue
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Therapeutic Nuclear Medicines Sales Channels
12.2.2 Therapeutic Nuclear Medicines Distributors
12.3 Therapeutic Nuclear Medicines Customers
13 Market Forecast
13.1 Global Therapeutic Nuclear Medicines Sales and Revenue Forecast 2019-2025
13.2 Global Therapeutic Nuclear Medicines Sales Forecast by Type
13.3 Global Therapeutic Nuclear Medicines Sales Forecast by Application
13.4 Therapeutic Nuclear Medicines Forecast by Regions
13.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Regions2019-2025
13.4.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Regions2019-2025
13.5 North America Market Forecast
13.5.1 North America Therapeutic Nuclear Medicines Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Therapeutic Nuclear Medicines Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Southeast Asia
13.8 Central & South America Market Forecast
13.8.1 Central & South America Therapeutic Nuclear Medicines Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales Forecast by Regions 2019-2025
13.9.2 Middle East
13.9.3 Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Therapeutic Nuclear Medicines Product Picture
Table Therapeutic Nuclear Medicines Key Market Segments
Table Major Manufacturers Therapeutic Nuclear Medicines Covered in This Report in 2018
Table Global Therapeutic Nuclear Medicines by Type
Table Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type (2018-2025) (K Unit) & (M USD)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2018
Figure Radium-223 Product Picture
Table Major Manufacturers of Radium-223
Figure Lutetium-177 Product Picture
Table Major Manufacturers of Lutetium-177
Figure Iodine-131 Product Picture
Table Major Manufacturers of Iodine-131
Table Global Therapeutic Nuclear Medicines Market Share by Application (2018-2025) (K Unit)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Application in 2018
Figure Thyroid Use Case
Figure Bone Metastasis Use Case
Figure Lymphoma Use Case
Figure Therapeutic Nuclear Medicines Report Years Considered
Figure Global Therapeutic Nuclear Medicines Market Size 2013-2025 (M USD)
Figure Global Therapeutic Nuclear Medicines Sales 2013-2018 (K Unit)
Table Global Therapeutic Nuclear Medicines Market Size by Regions 2018-2025 (K Unit) & (M USD)
Table Global Therapeutic Nuclear Medicines Sales by Regions 2013-2018 (K Unit)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2013-2018
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions 2013-2018
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Regions in 2018
Table Global Therapeutic Nuclear Medicines Revenue by Regions 2013-2018 (M USD)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Regions 2013-2018
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Market Drivers for Therapeutic Nuclear Medicines
Table Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2018) (K Unit)
Table Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2017-2018)
Figure Global Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2018
Table Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2018) (M USD)
Table Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2013-2018)
Figure Therapeutic Nuclear Medicines Value Share by Manufacturers in 2018
Figure Global Therapeutic Nuclear Medicines Manufacturers Top 5 Player Market Share
Table Key Manufacturers Therapeutic Nuclear Medicines Price (2017-2018) (USD/Unit)
Table Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution
Table Key Manufacturers Therapeutic Nuclear Medicines Area Served
Table Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market
Table Key Manufacturers Therapeutic Nuclear Medicines Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Radium-223 Sales and Revenue (2013-2018) (K Unit) & (M USD)
Table Global Lutetium-177 Sales and Revenue (2013-2018) (K Unit) & (M USD)
Table Global Iodine-131 Sales and Revenue (2013-2018) (K Unit) & (M USD)
Table Global Therapeutic Nuclear Medicines Sales by Type (2013-2018) (K Unit)
Table Global Therapeutic Nuclear Medicines Sales Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2018
Table Global Therapeutic Nuclear Medicines Revenue by Type (2013-2018) (M USD)
Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2018
Table Therapeutic Nuclear Medicines Price by Type (2013-2018) (USD/Unit)
Table Global Therapeutic Nuclear Medicines Market Share by Application (2018-2025) (K Unit)
Table Global Therapeutic Nuclear Medicines Sales by Application (2013-2018) (K Unit)
Table Global Therapeutic Nuclear Medicines Sales Share by Application (2013-2018)
Figure Global Therapeutic Nuclear Medicines Market Share by Application (2013-2018)
Figure Global Therapeutic Nuclear Medicines Market Share by Application (2013-2018)
Figure North America Therapeutic Nuclear Medicines Sales Growth Rate 2013-2018 (K Unit)
Figure North America Therapeutic Nuclear Medicines Revenue Growth Rate 2013-2018 (M USD)
Table North America Therapeutic Nuclear Medicines Revenue (M USD) by Company (2017-2018)
Table North America Therapeutic Nuclear Medicines Revenue Market Share by Company (2017-2018)
Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Company in 2018
Table North America Therapeutic Nuclear Medicines Revenue by Type (2013-2018) (M USD)
Table North America Therapeutic Nuclear Medicines Revenue Market Share by Type (2013-2018)
Figure North America Therapeutic Nuclear Medicines Market Share by Type in 2018
Table North America Therapeutic Nuclear Medicines Sales by Application (2013-2018) (K Unit)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure North America Therapeutic Nuclear Medicines Market Share by Application in 2018
Table North America Therapeutic Nuclear Medicines Sales by Countries (2013-2018) (K Unit)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2013-2018)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Table North America Therapeutic Nuclear Medicines Revenue by Countries (2013-2018) (M USD)
Table North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2013-2018)
Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure United States Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Europe Therapeutic Nuclear Medicines Sales Growth Rate 2013-2018 (K Unit)
Figure Europe Therapeutic Nuclear Medicines Revenue Growth Rate 2013-2018 (M USD)
Table Europe Therapeutic Nuclear Medicines Revenue by Company (2017-2018) (M USD)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Company (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Company in 2018
Table Europe Therapeutic Nuclear Medicines Revenue by Type (2013-2018) (M USD)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Type (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Market Share by Type in 2018
Table Europe Therapeutic Nuclear Medicines Sales by Application (2013-2018) (K Unit)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Market Share by Application in 2018
Table Europe Therapeutic Nuclear Medicines Sales by Countries (2013-2018) (K Unit)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Table Europe Therapeutic Nuclear Medicines Revenue by Countries (2013-2018) (M USD)
Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure France Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure UK Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Asia Pacific Therapeutic Nuclear Medicines Sales Growth Rate 2013-2018 (K Unit)
Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Growth Rate 2013-2018 (M USD)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Company (2017-2018) (M USD)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Company (2017-2018)
Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Company in 2018
Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2013-2018) (M USD)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Type (2013-2018)
Figure Asia Pacific Therapeutic Nuclear Medicines Market Share by Type in 2018
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2013-2018) (K Unit)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure Asia Pacific Therapeutic Nuclear Medicines Market Share by Application in 2018
Table Asia Pacific Therapeutic Nuclear Medicines Sales by Countries (2013-2018) (K Unit)
Table Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Countries (2013-2018)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue by Countries (2013-2018) (M USD)
Table Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Countries (2013-2018)
Figure Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure China Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018) (K Unit)
Figure China Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Japan Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018) (K Unit)
Figure Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Korea Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018) (K Unit)
Figure Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure India Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018) (K Unit)
Figure India Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Growth Rate (2013-2018) (K Unit)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue Growth Rate (2013-2018) (M USD)
Figure Central & South America Therapeutic Nuclear Medicines Sales Growth Rate 2014-2019 (K Unit)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report